Toward Personalized NSAID Therapy in Osteoarthritis: The Right Patient, the Right Treatment, at the Right Time
Life · 08.08.2026 · 16 (8) · 1303
DOI: 10.3390/life16081303 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 08.08.2026. Verfasst von Valerica Creanga Zarnescu und 4 weiteren Autor:innen. Beteiligte Einrichtung: The School for Doctoral Studies in Biomedical Sciences, "Dunărea de Jos" University of Galați, 800008 Galați, Romania. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Non-steroidal anti-inflammatory drugs (NSAIDs) remain the cornerstone of pharmacological treatment for osteoarthritis (OA) and are recommended by international guidelines for the management of symptomatic pain. Despite their well-established efficacy, substantial interindividual variability exists in treatment response, with some patients experiencing meaningful pain relief while others derive little clinical benefit despite appropriate drug selection and dosing. This variability reflects, at least in part, the biological heterogeneity of OA pain.
Objective
To review the mechanisms underlying variability in NSAID responsiveness in OA and to propose a practical framework for personalized NSAID prescribing based on pain phenotype, individual safety profile, and treatment timing.
Methods
A narrative review of the contemporary scientific literature was conducted using major biomedical databases to summarize the current evidence on phenotype-guided NSAID therapy in OA. Particular attention was given to the emerging concepts of nociceptive, nociplastic, and neuropathic-like pain phenotypes and their implications for personalized anti-inflammatory therapy.
Results
Current evidence indicates that OA pain is a heterogeneous and dynamic condition in which inflammatory nociceptive, nociplastic, and neuropathic-like mechanisms coexist to varying degrees. NSAIDs primarily target inflammatory nociceptive pain by inhibiting cyclooxygenase (COX)-mediated prostaglandin synthesis and reducing peripheral sensitization. Consequently, patients with predominantly inflammatory nociceptive pain are the most likely to benefit from NSAID therapy, whereas those with predominant nociplastic or neuropathic-like pain mechanisms may require alternative or multimodal treatment strategies. Beyond pain phenotype, optimal NSAID selection should integrate cardiovascular, gastrointestinal, and renal risk assessment, recognizing the important pharmacological and safety differences among individual agents. Treatment timing is also clinically relevant, as anti-inflammatory therapy appears most effective when initiated during periods of active inflammatory nociceptive pain. Based on the available evidence, we propose a conceptual clinical decision framework integrating patient selection, NSAID choice, and treatment timing.
Conclusions
Personalized NSAID prescribing should move beyond a diagnosis-based approach toward a mechanism-based strategy that integrates pain phenotyping, individualized safety assessment, and appropriate treatment timing. The proposed framework is built upon three complementary principles, identifying the right patient, selecting the right treatment, and initiating therapy at the right time. It provides a practical foundation for implementing precision medicine in the pharmacological management of OA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The School for Doctoral Studies in Biomedical Sciences, "Dunărea de Jos" University of Galați, 800008 Galați, Romania.
- Center of Physical Therapy, Rehabilitation and Wellness, "Dunărea de Jos" University of Galati, 800008 Galati, Romania.
- Grigore T. Popa University of Medicine and Pharmacy Iasi, 700454 Iasi, Romania.
- Department of Individual Sports and Kinetotherapy, Faculty of Physical Education and Sport, Dunarea de Jos University of Galati, 800008 Galati, Romania.
- Medical Department, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 800010 Galati, Romania.
ORCID-Profile: Liliana Mititelu-Tartau, Ilie Onu, Daniel Andrei Iordan
Zitieren
APA
Zarnescu, V. C., Mititelu-Tartau, L., Onu, I., Iordan, D. A., & Pavel, L. L. (2026). Toward Personalized NSAID Therapy in Osteoarthritis: The Right Patient, the Right Treatment, at the Right Time. Life, 16(8), 1303. https://doi.org/10.3390/life16081303
Vancouver
Zarnescu VC, Mititelu-Tartau L, Onu I, Iordan DA, Pavel LL. Toward Personalized NSAID Therapy in Osteoarthritis: The Right Patient, the Right Treatment, at the Right Time. Life. 2026;16(8):1303. doi:10.3390/life16081303
BibTeX
@article{Zarnescu2026,
author = {Zarnescu, Valerica Creanga and Mititelu-Tartau, Liliana and Onu, Ilie and Iordan, Daniel Andrei and Pavel, Liliana-Lăcrămioara},
title = {Toward Personalized NSAID Therapy in Osteoarthritis: The Right Patient, the Right Treatment, at the Right Time},
journal = {Life},
year = {2026},
volume = {16},
number = {8},
pages = {1303},
doi = {10.3390/life16081303}
}
EUVIMED